Business Standard

Top headlines: WHO clears Covaxin; Cairn cements end of tax dispute

Business Standard brings you the top headlines on Wednesday

Bharat Biotech has also finished administering the vaccines for its paediatric trial of Covaxin. Now, it is analysing the data before it can submit it to the regulator for review.
Premium

BS Web Team New Delhi
SBI's Q2 net profit surges 67% YoY to record Rs 7,627 crore

Country’s largest lender State Bank of India (SBI) on Wednesday reported a 67 per cent year-on-year (YoY) jump in net profit at Rs 7,627 crore in the July-September quarter (Q2FY22), aided by lower provisions. This is the highest ever quarterly net profit for the bank.

Net profit for the quarter beat street expectations as analysts had estimated a profit of Rs 7,450 crore. In the year-ago period, the bank had posted a net profit of Rs 4,574 crore. Read more

Tax dispute: Cairn gives undertakings

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in